Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
1996-12-16
pubmed:abstractText
To evaluate the efficacy and safety of 2 years' treatment of moderate benign prostatic hyperplasia (BPH) with finasteride.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8911291-1283370, http://linkedlifedata.com/resource/pubmed/commentcorrection/8911291-1383816, http://linkedlifedata.com/resource/pubmed/commentcorrection/8911291-2428671, http://linkedlifedata.com/resource/pubmed/commentcorrection/8911291-2643719, http://linkedlifedata.com/resource/pubmed/commentcorrection/8911291-4130099, http://linkedlifedata.com/resource/pubmed/commentcorrection/8911291-4384673, http://linkedlifedata.com/resource/pubmed/commentcorrection/8911291-4413434, http://linkedlifedata.com/resource/pubmed/commentcorrection/8911291-7505563, http://linkedlifedata.com/resource/pubmed/commentcorrection/8911291-7510911, http://linkedlifedata.com/resource/pubmed/commentcorrection/8911291-7527493, http://linkedlifedata.com/resource/pubmed/commentcorrection/8911291-7686980, http://linkedlifedata.com/resource/pubmed/commentcorrection/8911291-8558668, http://linkedlifedata.com/resource/pubmed/commentcorrection/8911291-8633398, http://linkedlifedata.com/resource/pubmed/commentcorrection/8911291-9099163
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0820-3946
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
155
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1251-9
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1996
pubmed:articleTitle
Efficacy and safety of finasteride therapy for benign prostatic hyperplasia: results of a 2-year randomized controlled trial (the PROSPECT study). PROscar Safety Plus Efficacy Canadian Two year Study.
pubmed:affiliation
Queen's University, Kingston, Ont.
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study